86.22.Z - Specialist medical practice activities
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
85.60.Z - Educational support activities
86.10.Z - Hospital activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 0 | 0 | -87,6 |
Gross profit (loss) | -0 | 0 | 0 | -87,6 |
EBITDA | -0 | 0 | 0 | -87,6 |
Short time liabilities | 0 | 0 | 0 | 249,1 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 0 | 0 | 0 | 6,3 |
Operating profit (EBIT) | -0 | 0 | 0 | -87,6 |
Assets | 0 | 0 | 0 | 57,9 |
Net profit (loss) | -0 | 0 | 0 | -88,3 |
Cash | 0 | 0 | 0 | -2,8 |
Net income from sale | 3,7 | 3,7 | 6,1 | 63,1 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 249,1 |
Working assets | 0 | 0 | 0 | 57,9 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -2,7 | 53,7 | 5,9 | -47,8 |
Equity capital to total assets | 63,7 | 78,7 | 53 | -25,7 |
Gross profit margin | -0 | 0,1 | 0 | -0,1 |
EBITDA Margin | -0 | 0,1 | 0 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Current financial liquidity indicator | 2.753934621810913 | 4.700141429901123 | 2.126396894454956 | -2,6 |
Net dept to EBITDA | 57.45731735229492 | -2.2559797763824463 | -17.677776336669922 | -15,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane